Document is current
Any future updates will be listed below
-
Authors
Ye, Xiyun https://orcid.org/0000-0002-5342-9244
Lee, Yen-Chun https://orcid.org/0000-0002-6961-6992
Gates, Zachary P.
Ling, Yingjie
Mortensen, Jennifer C. https://orcid.org/0000-0001-8080-337X
Yang, Fan-Shen
Lin, Yu-Shan
Pentelute, Bradley L. https://orcid.org/0000-0002-7242-801X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (LE 4224/1-1)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (K12 GM133314, R01 GM124160)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Calico Life Sciences
- License Information
-
More Information
Article History
Received: 12 February 2022
Accepted: 21 September 2022
First Online: 14 October 2022
Competing interests
: B.L.P. is a co-founder and/or member of the scientific advisory board of several companies focusing on the development of protein and peptide therapeutics. All other authors declare no competing interests.
